Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 9, 2026 · Filed Nov 10, 2026
A major shareholder of Starling Oncology paid $176K out of pocket for Starling Oncology shares. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$176,273
Shares × reported transaction price
$100K–$500K
+0.6%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 24 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
4 days after results of Nov 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any STLN insider since Mar 2025. Chernett Jorey's first open-market purchase of STLN in filings since 2021
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider filing
Traded Nov 11 · filed 3 days later
Not classified as an open-market trade.
Insider filing
Traded Nov 11 · filed 1 day later
Not classified as an open-market trade.
Insider selling
Traded Nov 6 · filed 4 days laterNot reported under a pre-arranged trading plan
A major shareholder of Starling Oncology sold $11.4M of Starling Oncology shares. The filing does not indicate a pre-arranged trading plan.
Chernett Jorey, 10% owner's past purchases, 90 days after disclosure: 21 buys, median +52.0 pts vs S&P 500, beat it 16 of 21 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.